Viking Therapeutics, Inc.
Industry: Life Sciences ・ $VKTX on Nasdaq
Insider Sale
+$1,000,320
-62.75%
Shares
Shares Volume: 16,000 Shares
Average Share Price: $62.52
INSIDER
SINGLETON J MATTHEW
Director
reported on Aug 19 2024
traded on Aug 19 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 9,500 |
PURCHASES/SALES 1Y | 0 / 2 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $1,102,330.42 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
PURCHASES/SALES 1Y | 0 / 14 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $3,652,860.15 |
COMPANY PREVIOUS TRADES |